- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Hadasit Bio Holdings Ltd
+ Add to WatchlistHADSY:US
1.7500 USD 0.00000.00%As of 20:10:00 ET on 06/17/2013.
Snapshot for Hadasit Bio Holdings Ltd (HADSY)
| Open: | - | Day's Range: | - | Volume: | 3,300 |
|---|---|---|---|---|---|
| Previous Close: | 1.7500 | 52wk Range: | 0.7145 - 2.5095 | 1-Yr Rtn: | -29.26% |
Key Statistics for HADSY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 1,312 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | 0.1047 |
| Last Dividend | 09/17/2012 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/22/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HADSY
Company Profile & Key Executives for HADSY
Hadasit Bio-Holdings Ltd., through subsidiaries, develops and researches diagnostic and treatment products and vaccinations. The Company researches products used to diagnose tumor malignancies, radiology-based products to diagnose, monitor and treat cancer, products to manage stroke, heart attack, and inflammatory and autoimmune diseases, and a rheumatoid arthritis vaccine.
| Raphael Hofstein "Rafi"Chairman | Ophir SahafChief Executive Officer |
| Liat HadadChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HADSY News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page